Etiology, evaluation, and management of xerostomia

Mortazavi, 2014, Xerostomia due to systemic disease: A review of 20 conditions and mechanisms, Ann Med Health Sci Res, 4, 503, 10.4103/2141-9248.139284 Villa, 2015, Diagnosis and management of xerostomia and hyposalivation, Ther Clin Risk Manag, 11, 45 Han, 2015, Dry mouth: A critical topic for older adult patients, J Prosthodont Res, 59, 6, 10.1016/j.jpor.2014.11.001 Tanasiewicz, 2016, Xerostomia of various etiologies: A review of the literature, Adv Clin Exp Med, 25, 199, 10.17219/acem/29375 Pedersen, 2002, Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion, Oral Dis, 8, 117, 10.1034/j.1601-0825.2002.02851.x Villa, 2011, Dental patients’ self-reports of xerostomia and associated risk factors, J Am Dent Assoc, 142, 811, 10.14219/jada.archive.2011.0269 Vasconcelos, 2010, Comparative study of the concentration of salivary and blood glucose in type 2 diabetic patients, J Oral Sci, 52, 293, 10.2334/josnusd.52.293 Bakianian Vaziri, 2010, Evaluation of salivary glucose, IgA and flow rate in diabetic patients: A case-control study, J Dent (Tehran), 7, 13 Busato, 2009, Impact of xerostomia on the quality of life of adolescents with type 1 diabetes mellitus, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, 376, 10.1016/j.tripleo.2009.05.005 Costa, 2004, Study of the oral manifestations in diabetic children and their correlation variables, Arq Bras Endocrinol Metabol, 48, 374, 10.1590/S0004-27302004000300007 Khovidhunkit, 2009, Xerostomia, hyposalivation, and oral microbiota in type 2 diabetic patients: A preliminary study, J Med Assoc Thail, 92, 1220 Bajaj, 2012, Oral manifestations in type-2 diabetes and related complications, Indian J Endocrinol Metab, 16, 777, 10.4103/2230-8210.100673 Karsh, 1980, Thyroid disease in Sjogren’s syndrome, Arthritis Rheum, 23, 1326, 10.1002/art.1780231118 Anaya, 1999, Sjogren’s syndrome comes of age, Semin Arthritis Rheum, 28, 355, 10.1016/S0049-0172(99)80001-8 Fox, 2000, Update in Sjogren syndrome, Curr Opin Rheumatol, 12, 391, 10.1097/00002281-200009000-00007 Dawson, 2006, Antimuscarinic antibodies in primary Sjogren’s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells, Arthritis Rheum, 54, 1165, 10.1002/art.21764 Jensen, 1999, Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus, J Oral Pathol Med, 28, 317, 10.1111/j.1600-0714.1999.tb02047.x Zalewska, 2013, Rheumatoid arthritis patients with xerostomia have reduced production of key salivary constituents, Oral Surg Oral Med Oral Pathol Oral Radiol, 115, 483, 10.1016/j.oooo.2012.10.013 Gupta, 2006, Hyposalivation in elderly patients, J Can Dent Assoc, 72, 841 Albilia, 2007, Small mouths... Big problems? A review of scleroderma and its oral health implications, J Can Dent Assoc, 73, 831 Mang, 1997, Primary biliary cirrhosis, sicca complex, and dysphagia, Dysphagia, 12, 167, 10.1007/PL00009532 Kumagi, 2008, Primary biliary cirrhosis, Orphanet J Rare Dis, 3, 1, 10.1186/1750-1172-3-1 Selmi, 2012, Primary biliary cirrhosis and Sjogren’s syndrome: Autoimmune epithelitis, J Autoimmun, 39, 34, 10.1016/j.jaut.2011.11.005 Mamais, 2011, Parotid actinomycosis mimicking metastatic lymphadenopathy, West Indian Med J, 60, 349 Sittitrai, 2012, Actinomycosis presenting as a parotid tumor, Auris Nasus Larynx, 39, 241, 10.1016/j.anl.2011.03.011 Reznik, 2005, Oral manifestations of HIV disease, Top HIV Med, 13, 143 Sharma, 2006, Oral manifestations in HIV/AIDS infected patients from India, Oral Dis, 12, 537, 10.1111/j.1601-0825.2006.01232.x Taiwo, 2006, Oral manifestation of HIV/AIDS in Plateau state indigenes, Nigeria, West Afr J Med, 25, 32 Freed, 2005, Oral health findings for HIV-infected adult medical patients from the HIV Cost and Services Utilization Study, J Am Dent Assoc, 136, 1396, 10.14219/jada.archive.2005.0053 Sontakke, 2011, Comparison of oral manifestations with CD4 count in HIV-infected patients, Indian J Dent Res, 22, 732, 10.4103/0970-9290.93470 Pinheiro, 2004, Dental and oral lesions in HIV infected patients: A study in Brazil, Int Dent J, 54, 131, 10.1111/j.1875-595X.2004.tb00268.x Obermayer-Straub, 2001, Hepatitis C and D, retroviruses and autoimmune manifestations, J Autoimmun, 16, 275, 10.1006/jaut.2000.0488 Lee, 2012, Detection of HTLV-1 in the labial salivary glands of patients with Sjogren’s syndrome: A distinct clinical subgroup?, J Rheumatol, 39, 809, 10.3899/jrheum.111075 Hida, 1999, HTLV-I associated Sjogren’s syndrome is aetiologically distinct from anti-centromere antibodies positive Sjogren’s syndrome, Ann Rheum Dis, 58, 320, 10.1136/ard.58.5.320 Ohyama, 1998, Accumulation of human T lymphotropic virus type I-infected T cells in the salivary glands of patients with human T lymphotropic virus type I-associated Sjogren’s syndrome, Arthritis Rheum, 41, 1972, 10.1002/1529-0131(199811)41:11<1972::AID-ART12>3.0.CO;2-M Ramos-Casals, 2003, Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection, Rheumatology, 42, 818, 10.1093/rheumatology/keg299 Grossmann Sde, 2010, Xerostomia, hyposalivation and sialadenitis in patients with chronic hepatitis C are not associated with the detection of HCV RNA in saliva or salivary glands, J Clin Pathol, 63, 1002, 10.1136/jcp.2010.080036 Nawito, 2011, Sicca complex among Egyptian patients with chronic hepatitis C virus infection, Clin Rheumatol, 30, 1299, 10.1007/s10067-011-1746-x Giordano, 2005, Immune and autoimmune disorders in HCV chronic liver disease: Personal experience and commentary on literature, New Microbiol, 28, 311 Nagao, 2012, Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases, BMC Gastroenterol, 12, 155, 10.1186/1471-230X-12-155 Aghemo, 2011, Ribavirin impairs salivary gland function during combination treatment with pegylated interferon alfa-2a in hepatitis C patients, Hepat Mon, 11, 918 Burns, 1983, Persistent cytomegalovirus infection—the etiology of Sjogren’s syndrome, Med Hypotheses, 10, 451, 10.1016/0306-9877(83)90011-7 Babazade, 2012, Parotid tuberculosis: A forgotten suspicion (a case report and literature review), Int J Dermatol, 51, 588, 10.1111/j.1365-4632.2011.05014.x Mansour, 2007, Coexistence of Sjogren’s syndrome and sarcoidosis: A report of five cases, J Oral Pathol Med, 36, 337, 10.1111/j.1600-0714.2007.00530.x Hull, 2012, Long-term oral complications of allogeneic haematopoietic SCT, Bone Marrow Transplant, 47, 265, 10.1038/bmt.2011.63 de la Rosa, 2006, Graft-versus-host disease, an eight case report and literature review, Med Oral Patol Oral Cir Bucal, 11, E486 Postorino, 2003, Salivary and lacrimal secretion is reduced in patients with ESRD, Am J Kidney Dis, 42, 722, 10.1016/S0272-6386(03)00908-9 Dirschnabel, 2011, Clinical oral findings in dialysis and kidney-transplant patients, Quintessence Int, 42, 127 Sanchez-Pablo, 2012, Study of total stimulated saliva flow and hyperpigmentation in the oral mucosa of patients diagnosed with hereditary hemochromatosis. Series of 25 cases, Med Oral Patol Oral Cir Bucal, 17, e45, 10.4317/medoral.17206 Wey, 2011, Primary sjogren syndrome manifested as localized cutaneous nodular amyloidosis, J Clin Rheumatol, 17, 368, 10.1097/RHU.0b013e31823209ba Proulx, 2005, Salivary production in Parkinson’s disease, Mov Disord, 20, 204, 10.1002/mds.20189 Turner, 2016, Hyposalivation and xerostomia: Etiology, Complications, and Medical management, Dent Clin N Am, 60, 435, 10.1016/j.cden.2015.11.003 Lexner, 2007, Whole saliva in X-linked hypohidrotic ectodermal dysplasia, Int J Paediatr Dent, 17, 155, 10.1111/j.1365-263X.2006.00812.x Nordgarden, 2001, Oligodontia is associated with extra-oral ectodermal symptoms and low whole salivary flow rates, Oral Dis, 7, 226 Tylenda, 1988, Evaluation of submandibular salivary flow rate in different age groups, J Dent Res, 67, 1225, 10.1177/00220345880670091501 Baum, 1982, Exocrine protein secretion from human parotid glands during aging: Stable release of the acidic proline-rich proteins, J Gerontol, 37, 392, 10.1093/geronj/37.4.392 Finkelstein, 1984, Salivary and serum IgA levels in a geriatric outpatient population, J Clin Immunol, 4, 85, 10.1007/BF00915040 Smith, 2013, Effect of aging on stimulated salivary flow in adults, J Am Geriatr Soc, 61, 805, 10.1111/jgs.12219 Yeh, 1998, Impact of aging on human salivary gland function: A community-based study, Aging (Milano), 10, 421 Thomson, 2015, Dry mouth and older people, Aust Dent J, 60, 54, 10.1111/adj.12284 Sreebny, 1997, A reference guide to drugs and dry mouth—2nd edition, Gerodontology, 14, 33, 10.1111/j.1741-2358.1997.00033.x Saleh, 2015, Salivary hypofunction: An update on aetiology, diagnosis and therapeutics, Arch Oral Biol, 60, 242, 10.1016/j.archoralbio.2014.10.004 Wick, 2007, Xerostomia: causes and treatment, Consult Pharm, 22, 985, 10.4140/TCP.n.2007.985 Valdez, 1993, Diagnosis and management of salivary dysfunction, Crit Rev Oral Biol Med, 4, 271, 10.1177/10454411930040030301 van der Putten, 2011, The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents, Clin Oral Investig, 15, 185, 10.1007/s00784-010-0382-1 Fox, 1987, Subjective reports of xerostomia and objective measures of salivary gland performance, J Am Dent Assoc, 115, 581, 10.1016/S0002-8177(87)54012-0 Thomson, 1999, The Xerostomia Inventory: A multi-item approach to measuring dry mouth, Community Dent Health, 16, 12 Eisbruch, 2003, How should we measure and report radiotherapy-induced xerostomia?, Semin Radiat Oncol, 13, 226, 10.1016/S1053-4296(03)00033-X Pai, 2001, Development of a visual analogue scale questionnaire for subjective assessment of salivary dysfunction, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 91, 311, 10.1067/moe.2001.111551 Thomson, 2011, Shortening the xerostomia inventory, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 112, 322, 10.1016/j.tripleo.2011.03.024 Osailan, 2011, Investigating the relationship between hyposalivation and mucosal wetness, Oral Dis, 17, 109, 10.1111/j.1601-0825.2010.01715.x Humphrey, 2001, A review of saliva: Normal composition, flow, and function, J Prosthet Dent, 85, 162, 10.1067/mpr.2001.113778 Heintze, 1983, Secretion rate and buffer effect of resting and stimulated whole saliva as a function of age and sex, Swed Dent J, 7, 227 Dawes, 2004, How much saliva is enough for avoidance of xerostomia?, Caries Res, 38, 236, 10.1159/000077760 Navazesh, 1993, Methods for collecting saliva, Ann N Y Acad Sci, 694, 72, 10.1111/j.1749-6632.1993.tb18343.x Chen, 2005, Using the modified Schirmer test to measure mouth dryness: A preliminary study, J Am Dent Assoc, 136, 164, 10.14219/jada.archive.2005.0137 Navazesh, 2008, Measuring salivary flow: Challenges and opportunities, J Am Dent Assoc, 139, 35S, 10.14219/jada.archive.2008.0353 Kruszka, 2009, Diagnosis and management of Sjogren syndrome, Am Fam Physician, 79, 465 Teymoortash, 2009, Botulinum toxin prevents radiotherapy-induced salivary gland damage, Oral Oncol, 45, 737, 10.1016/j.oraloncology.2008.11.014 Limesand, 2010, Insulin-like growth factor-1 preserves salivary gland function after fractionated radiation, Int J Radiat Oncol Biol Phys, 78, 579, 10.1016/j.ijrobp.2010.03.035 Lombaert, 2008, Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool, Stem Cells, 26, 2595, 10.1634/stemcells.2007-1034 Ogawa, 2013, Functional salivary gland regeneration by transplantation of a bioengineered organ germ, Nat Commun, 4, 2498, 10.1038/ncomms3498 Vitolo, 2004, The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model, Clin Cancer Res, 10, 1807, 10.1158/1078-0432.CCR-03-0194 Radvansky, 2013, Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia, Am J Health Syst Pharm, 70, 1025, 10.2146/ajhp120467 Aframian, 2007, Pilocarpine treatment in a mixed cohort of xerostomic patients, Oral Dis, 13, 88, 10.1111/j.1601-0825.2006.01252.x Nieuw Amerongen, 2003, Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies, Support Care Cancer, 11, 226, 10.1007/s00520-002-0409-5 Jham, 2007, A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer, Oral Oncol, 43, 137, 10.1016/j.oraloncology.2006.01.013 Hamada, 1999, Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: A clinical trial, Am J Med Sci, 318, 146, 10.1016/S0002-9629(15)40606-8 Bagheri, 1997, A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs, Eur J Clin Pharmacol, 52, 339, 10.1007/s002280050298 Olsson, 1991, The effect of a chewing gum on salivary secretion, oral mucosal friction, and the feeling of dry mouth in xerostomic patients, Acta Odontol Scand, 49, 273, 10.3109/00016359109005919 van der Reijden, 1999, Treatment of oral dryness related complaints (xerostomia) in Sjogren’s syndrome, Ann Rheum Dis, 58, 465, 10.1136/ard.58.8.465 Hahnel, 2009, Saliva substitutes for the treatment of radiation-induced xerostomia—a review, Support Care Cancer, 17, 1331, 10.1007/s00520-009-0671-x Vissink, 2010, Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: Successes and barriers, Int J Radiat Oncol Biol Phys, 78, 983, 10.1016/j.ijrobp.2010.06.052 Gomez-Moreno, 2013, The efficacy of a topical sialogogue spray containing 1% malic acid in patients with antidepressant-induced dry mouth: A double-blind, randomized clinical trial, Depress Anxiety, 30, 137, 10.1002/da.22017 Gomez-Moreno, 2013, Effectiveness of malic acid 1% in patients with xerostomia induced by antihypertensive drugs, Med Oral Patol Oral Cir Bucal, 18, e49, 10.4317/medoral.18206 Mouly, 2007, Management of xerostomia in older patients: A randomised controlled trial evaluating the efficacy of a new oral lubricant solution, Drugs Aging, 24, 957, 10.2165/00002512-200724110-00007 Blixt-Johansen, 1992, Improvement of oral mucosa with mucin containing artificial saliva in geriatric patients, Arch Gerontol Geriatr, 14, 193, 10.1016/0167-4943(92)90054-8 Duxbury, 1989, A double-blind cross-over trial of a mucin-containing artificial saliva, Br Dent J, 166, 115, 10.1038/sj.bdj.4806731 Sweeney, 1997, Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients, Palliat Med, 11, 225, 10.1177/026921639701100307 Gravenmade, 1993, Mucin-containing lozenges in the treatment of intraoral problems associated with Sjogren’s syndrome. A double-blind crossover study in 42 patients, Oral Surg Oral Med Oral Pathol, 75, 466, 10.1016/0030-4220(93)90172-Z Ship, 2007, Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth, J Oral Rehabil, 34, 724, 10.1111/j.1365-2842.2006.01718.x O’Sullivan, 2010, Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: A systematic review, Acupunct Med, 28, 191, 10.1136/aim.2010.002733 Alajbeg, 2012, Intraoral electrostimulator for xerostomia relief: A long-term, multicenter, open-label, uncontrolled, clinical trial, Oral Surg Oral Med Oral Pathol Oral Radiol, 113, 773, 10.1016/j.oooo.2012.01.012 Teguh, 2009, Early hyperbaric oxygen therapy for reducing radiotherapy side effects: Early results of a randomized trial in oropharyngeal and nasopharyngeal cancer, Int J Radiat Oncol Biol Phys, 75, 711, 10.1016/j.ijrobp.2008.11.056 Gu, 2014, Effect of amifostine in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis based on randomized controlled trials, PLoS One, 9, e95968, 10.1371/journal.pone.0095968